Ding F - Search Results

1

CD56^dim CD16^- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.

Vujanovic L, Chuckran C, Lin Y, Ding F, Sander CA, Santos PM, Lohr J, Mashadi-Hossein A, Warren S, White A, Huang A, Kirkwood JM, Butterfield LH. Vujanovic L, et al. Among authors: ding f. Front Immunol. 2019 Jan 29;10:14. doi: 10.3389/fimmu.2019.00014. eCollection 2019. Front Immunol. 2019. PMID: 30761123 Free PMC article.

2

Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.

Ross K, Gillespie-Twardy AL, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Duggal S, Ding F, Lin Y, Boyiadzis M. Ross K, et al. Among authors: ding f. Oncol Res. 2015;22(2):85-92. doi: 10.3727/096504014X14146137738547. Oncol Res. 2015. PMID: 25706395 Free PMC article.

3

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.

Najjar YG, Ding F, Lin Y, VanderWeele R, Butterfield LH, Tarhini AA. Najjar YG, et al. Among authors: ding f. J Transl Med. 2017 Feb 21;15(1):39. doi: 10.1186/s12967-017-1140-9. J Transl Med. 2017. PMID: 28222797 Free PMC article. Clinical Trial.

4

A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.

Ferris LK, Saul MI, Lin Y, Ding F, Weinstock MA, Geller AC, Yuan JM, Neuren E, Maddukuri S, Solano FX, Kirkwood JM. Ferris LK, et al. Among authors: ding f. JAMA Oncol. 2017 Aug 1;3(8):1112-1115. doi: 10.1001/jamaoncol.2016.6779. JAMA Oncol. 2017. PMID: 28241191 Free PMC article.

5

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute.

Davar D, Ding F, Saul M, Sander C, Tarhini AA, Kirkwood JM, Tawbi HA. Davar D, et al. Among authors: ding f. J Immunother Cancer. 2017 Sep 19;5(1):74. doi: 10.1186/s40425-017-0279-5. J Immunother Cancer. 2017. PMID: 28923120 Free PMC article.

6

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response.

Kansy BA, Shayan G, Jie HB, Gibson SP, Lei YL, Brandau S, Lang S, Schmitt NC, Ding F, Lin Y, Ferris RL. Kansy BA, et al. Among authors: ding f. Oncoimmunology. 2018 Aug 24;7(11):e1494112. doi: 10.1080/2162402X.2018.1494112. eCollection 2018. Oncoimmunology. 2018. PMID: 30377562 Free PMC article.

7

Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.

Shurin GV, Kruglov O, Ding F, Lin Y, Hao X, Keskinov AA, You Z, Lokshin AE, LaFramboise WA, Falo LD Jr, Shurin MR, Bunimovich YL. Shurin GV, et al. Among authors: ding f. Cancer Res. 2019 May 15;79(10):2736-2747. doi: 10.1158/0008-5472.CAN-18-3872. Epub 2019 Mar 26. Cancer Res. 2019. PMID: 30914431 Free PMC article.

8

APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.

Faden DL, Ding F, Lin Y, Zhai S, Kuo F, Chan TA, Morris LG, Ferris RL. Faden DL, et al. Among authors: ding f. Oral Oncol. 2019 Sep;96:140-147. doi: 10.1016/j.oraloncology.2019.07.020. Epub 2019 Jul 30. Oral Oncol. 2019. PMID: 31422205 Free PMC article.

9

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study.

Najjar YG, Navrazhina K, Ding F, Bhatia R, Tsai K, Abbate K, Durden B, Eroglu Z, Bhatia S, Park S, Chowdhary A, Chandra S, Kennedy J, Puzanov I, Ernstoff M, Vachhani P, Drabick J, Singh A, Xu T, Yang J, Carvajal R, Manson D, Kirkwood JM, Cohen J, Sullivan R, Johnson D, Funchain P, Shoushtari A. Najjar YG, et al. Among authors: ding f. J Immunother Cancer. 2020 Jun;8(1):e000331. doi: 10.1136/jitc-2019-000331. J Immunother Cancer. 2020. PMID: 32581057 Free PMC article.

10

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma.

Storkus WJ, Maurer D, Lin Y, Ding F, Bose A, Lowe D, Rose A, DeMark M, Karapetyan L, Taylor JL, Chelvanambi M, Fecek RJ, Filderman JN, Looney TJ, Miller L, Linch E, Lowman GM, Kalinski P, Butterfield LH, Tarhini A, Tawbi H, Kirkwood JM. Storkus WJ, et al. Among authors: ding f. J Immunother Cancer. 2021 Nov;9(11):e003675. doi: 10.1136/jitc-2021-003675. J Immunother Cancer. 2021. PMID: 34782430 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,983 results

Search Page